FDA names Cavi as papaya brand in Salmonella outbreak

More News Top Stories
FDA names Cavi as papaya brand in Salmonella outbreak

The U.S. Food and Drug Administration (FDA) has identified the papaya brand in the current Salmonella as Cavi, and now says that only this label should be avoided.

The investigation into a multistate outbreak of Salmonella Uganda indicates that Agroson’s LLC of Bronx, New York, is the exclusive distributor of the imported papayas that likely made consumers from this outbreak sick, according to the FDA.

"The papayas are sold under the brand name Cavi. To date, there have been no positive product samples," it says.

Of the 71 illnesses, 69 have been reported in six states in the Northeast. One patient from Florida who was reported ill had traveled to Connecticut before becoming ill. Another patient from Texas who was also reported ill had traveled to New York before becoming ill.

The FDA says it has consulted with the firm on the possibility of a recall. 

The evidence does not indicate that papayas from other distributors are currently implicated at this time, and the FDA is no longer recommending that all Mexican papayas be avoided.

"The FDA strongly advises importers, suppliers, and distributors, as well as restaurants, retailers, and other food service providers from all states to not sell or distribute whole, fresh papayas from Agroson’s LLC that are labeled under the Cavi brand," it says.

The FDA says it will continue its investigation to try to determine the root cause of the contamination of the implicated brand.


Subscribe to our newsletter